3
1
1
intermolecular hydrogen bond (Fig. 2). However, the crystal
grown by slow evaporation from more polar ethyl acetate existed
References and notes
12
only as 1-acridin-9-yl-3-tert-butyl-urea (tautomer 5a). The
single crystal X-ray data show that the dihydroacridine fragment
of compound 5b was not planar and the angle between the planes
of the two benzene rings was 7.63°.
1. (a) Wainwright, M. J. Antimicrob. Chemother. 2001, 47, 1. (b)
Gamage, S. A.; Figgitt, D. P.; Wojcik, S. J.; Ralph, R. K.; Ransijn,
A.; Mauel, J.; Yardley, V.; Snowdon, D.; Croft, S. L.; Denny, W.
A. J. Med. Chem. 1997, 40, 2634. (c) Chauhan, P. M.; Srivastava,
S. K. Curr. Med. Chem. 2001, 8, 1535. (d) Kumar, R.; Kaur, M.;
Kumari, M.. Acta Poloniae Pharmaceutica-Drug Research, 2012,
6
9, 3. (e) Hamy, F.; Brondani, V.; Flörsheimer, A.; Stark, W.;
Blommers, M. J. J.; Klimkait, T. Biochemistry 1998, 37, 5086. (f)
Belmont, P.; Bosson, J.; Godet, T.; Tiano, M. Anti-Cancer Agents
Med. Chem. 2007, 7, 139.
2
.
(a) Campbell, N. H.; Parkinson, G. N.; Reszka, A. P.; Neidle, S. J.
Am. Chem. Soc. 2008, 130, 6722. (b) Bridewell, D. J.; Finlay, G.
J.; Baguley, B. C. Anti-Cancer Drug Des. 2001, 16, 317. (c) Rene,
B.; Fosse, P.; Khelifa, T.; Jacquemin-Sablon, A.; Bailly, C. Mol.
Pharmacol. 1996, 49, 343. (d) Denny, W. A. Anti-Cancer Drug
Des. 1989, 4, 241.
3
4
.
.
(a) Moore, M. J.; Schultes, C. M.; Cuesta, J.; Cuenca, F.;
Gunaratnam, M.; Tanious, F. A.; Wilson, W. D.; Neidle, S. J.
Med. Chem. 2006, 49, 582. (b) Kumar, P.; Kumar, R.; Prasad, D.
N. Arab. J. Chem. 2013, 6, 79.
(a) Burger, A. M.; Dai, F.; Schultes, C. M.; Reszka, A. P.; Moore,
M. J.; Double, J. A.; Neidle, S. Cancer Res. 2005, 65, 1489. (b)
Oppegard, L. M.; Ougolkov, A. V.; Luchini, D. N.; Schoon, R. A.;
Goodell, J. R.; Kaur, H.; Billadeau, D. D.; Ferguson, D. M.; Hiasa,
H. Eur. J. Pharmacol. 2009, 602, 223.
5
.
see reviews: (a) Chiron, J.; Galy, J.-P. Synthesis 2004, No. 3, 313.
(
Figure 2. ORTEP diagram of compounds 5a,b.
b) Skonieczny, S. Heterocycles 1980, 14,. 985. (c) Albert, A. In
The Acridines, 2nd Ed.; St. Martin’s Press: New York, 1966. (d)
Acheson, R. M. In Acridines, 2nd Ed.; John Wiley & Sons: New
York, 1973.
In contrast to products 4-6 the tautomeric equilibrium for
compounds 7-10 in DMSO was almost completely shifted
towards one tautomer. To identify in which form they existed in
DMSO, COSY, NOESY, HSQC and HMBC NMR experiments
were performed. As it turned out, their preferred tautomeric
forms were imino forms 7b-10b. This was in accordance with the
6. (a) Bauer, K. Ber. 1950, 83, 10. (b) Pozharskii, A. F.;
Konstantinchenko, A. A. Chem. Heterocycl. Compd. 1972, 8,
1
518. (c) Kitahara, T.; Ishihara, Y.; Takano, J. Nippon Kagaku
Kaishi 1997, 12, 876; Chem. Abstr. 1997, 128: 22802.
Borovlev, I. V.; Demidov, O. P.; Amangasieva, G. A.; Avakyan,
E. K.; Kurnosova, N. A. Arkivoc, 2016, 58.
7
.
9
a
9
observation that any hindrance for free rotation around the C -N
bond in 9-alkylaminoacridines makes the imino form more
preferable.
8. General procedure: To a solution of the corresponding urea (3
mmol) in anhydrous dimethyl sulfoxide (5 mL), sodium hydride (3
mmol, based on active ingredient) was added at room temperature.
When hydrogen bubbling ceased, acridine (0.5 mmol) was added.
The mixture was stirred vigorously at room temperature for 24 h.
Then water (30 mL) was added and the precipitate was filtered off,
washed with water and dried. Compounds 3, 7 and 10 were
purified by recrystallization from the appropriate solvents (see
ESI). Product 6 was additionally washed with hot water on the
filter (~70 °C; 40 mL) during isolation to remove excess starting
materials and the dry product was recrystallized from a mixture of
dichloromethane and petroleum-ether. Compound 5 was purified
by silica gel flash chromatography, eluting with a 5:1 mixture of
benzene-EtOAc (colorless fraction) and then with EtOAc (yellow
fraction). The first fraction containing the starting materials was
discarded; product 5 was obtained from the second fraction after
solvent evaporation.
1
A distinctive feature of the H NMR spectrum of compound 7
was the magnetic nonequivalence of the N-methyl groups which
gave two proton singlets at 2.82 and 3.01 ppm, i.e. they are
1
3
separated by 76 Hz. In the C NMR spectrum there were also
two carbon signals. A similar phenomenon was observed in the
NMR spectra of compounds 8-10, where individual signals were
formed from the α-methylene groups at the nitrogen atom as well
as the β-methylene groups. This may be explained in at least two
ways: (i) the known restricted rotation about the C-N bond for
amides or (ii) the influence of the magnetic field of the benzene
ring in the region of these substituents.
Compounds 4-10 were unstable upon heating in the crystalline
state as well as in solution and upon slow heating gradually
change color and eventually melt at the melting point of 9-
aminoacridine 3.
Data for 9-aminoacridine (3): yellow solid (76 mg, 78% upon use
o
urea and 72 mg, 74%, using phenyl urea); mp 232-233
C
6
b
o
(EtOAc). Lit mp 233-234 C. H NMR (400 MHz, DMSO-d
1
6
): δ
.39 (2H, br. d, J = 8.4 Hz, H-1,8); 7.81 (2H, br. d, J = 8.5 Hz, H-
8
4
In conclusion, the advantages of the described method for the
synthesis of 9-aminoacridine and acridin-9-yl-ureas include
reagent availability, experimental simplicity and its applicability
to the synthesis of a broad range of 9-amino substituted acridines.
The crystal structure and tautomerism of selected compounds
were investigated.
,5); 7.77 (2H, br. s, NH ); 7.64 (2H, ddd, J = 8.5 Hz, J = 8.0 Hz,
2
J = 1.0 Hz, H-3,6); 7.31 (2H, ddd, J = 8.4 Hz, J = 8.0 Hz, J = 1.0
13
Hz, H-2,7). C NMR (100 MHz, DMSO-d
6
): δ 150.1; 148.8;
1
29.8; 128.7; 123.3; 121.5; 112.9. IR (thin film) 3342, 3181, 1649,
+
-
1
1613, 1562 cm . ESI-HRMS: calcd for
95.0917, found 195.0919.
C
13
H
11
N
2
[М+H]
1
9
.
(a) Stezowski, J. J.; Kollat, P.; Bogucka-Ledochowska, M. P;
Glusker, J. J. Am. Chem. Soc. 1985, 107, 2067. (b) Rak, J.;
Blazejowski, J.; Zauhar, R. J. J. Org. Chem. 1992, 57, 3720. (c)
Boyd, M.; Denny, W. A. J. Med. Chem. 1990, 33, 2656.
Acknowledgments
This project received financial support from the Ministry of
Education and Scienceof the Russian Federation in the
framework of the State Assignment to the Higher Education
Institutions № 4.141.2014/K.
10. Procedure for the synthesis of 1-tert-butyl-3-(10-methyl-10H-
acridin-9-ylidene)-urea (11) and 1-(acridin-9-yl)-3-tert-butyl-1-
methyl-urea (12). To a solution of 1-acridin-9-yl-3-tert-butyl-urea
(
5; 147 mg, 0.5 mmol) in anhydrous acetonitrile (5 mL), sodium
hydride (20 mg, 0.5 mmol, based on active ingredient) was added
at room temperature. After stirring for 0.5 h methyl iodide (71 mg,
0
.5 mmol) was added and the mixture was stirred for 1.5 hours at
room temperature. Then water (20 mL) was added and the
precipitate was filtered off, washed with water and dried.